0000791908-15-000091.txt : 20150717
0000791908-15-000091.hdr.sgml : 20150717
20150717180317
ACCESSION NUMBER: 0000791908-15-000091
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150715
FILED AS OF DATE: 20150717
DATE AS OF CHANGE: 20150717
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: XOMA Corp
CENTRAL INDEX KEY: 0000791908
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 942756657
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2910 SEVENTH ST
CITY: BERKELEY
STATE: CA
ZIP: 94710
BUSINESS PHONE: 5106441170
MAIL ADDRESS:
STREET 1: 2910 SEVENTH ST
CITY: BERKELEY
STATE: CA
ZIP: 94710
FORMER COMPANY:
FORMER CONFORMED NAME: XOMA LTD /DE/
DATE OF NAME CHANGE: 19990107
FORMER COMPANY:
FORMER CONFORMED NAME: XOMA CORP /DE/
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Varian John
CENTRAL INDEX KEY: 0001416176
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14710
FILM NUMBER: 15994703
MAIL ADDRESS:
STREET 1: ARYX THERAPEUTICS,INC.
STREET 2: 6300 DUMBARTON CIRCLE
CITY: FREMONT
STATE: CA
ZIP: 94555
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2015-07-15
0
0000791908
XOMA Corp
XOMA
0001416176
Varian John
C/O XOMA CORPORATION
2910 SEVENTH STREET
BERKELEY
CA
94710
1
1
0
0
CEO
Common Shares
2015-07-15
4
M
0
10000.0
1.24
A
562414
D
Common Shares
2015-07-15
4
S
0
10000.0
4.4869
D
552414
D
Common Shares
18538
I
by 401(k)
Incentive Share Option (right to buy)
1.24
2015-07-15
4
M
0
10000.0
1.24
D
2022-01-04
Common Shares
10000
70392
D
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2014.
This transaction was executed in multiple trades ranging at prices from $4.36 to $4.64. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Company or a security holder of the Company full information regarding the number of shares and prices at which the transactions were effected.
Incentive Stock Option exercisable in conjunction with matching Non-Qualified Stock Option as to forty-eight (48) equal and consecutive monthly installments beginning one month after the date of grant.
By: Russell J. Wood For: John Varian
2015-07-17